Amneal Pharmaceuticals (AMRX) Cash from Investing Activities (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted Cash from Investing Activities of -$122.7 million for Q2 2026, down 465.37% on a QoQ basis from -$21.7 million in Q1 2026, and down 362.36% year-over-year from $46.8 million in Q2 2025.
Amneal Pharmaceuticals (AMRX) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals has reported Cash from Investing Activities for 10 years, with the latest figure at -$122.7 million in Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 362.36% year-over-year to -$122.7 million in Q2 2026; TTM through Jun 2026 was -$212.4 million, a 161.81% decrease from a year earlier, with the FY2025 full-year figure at -$112.3 million, down 78.21% from the prior year.
- Cash from Investing Activities was -$122.7 million for Q2 2026 at Amneal Pharmaceuticals, down from -$21.7 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$6.5 million in Q2 2024, with the low at -$122.7 million in Q2 2026.
- Average Cash from Investing Activities over 5 years is -$31.3 million, with a median of -$20.2 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities sank 667.31% in 2022, then surged 87.95% in 2023.
- Over 5 years, Cash from Investing Activities stood at -$11.5 million in 2022, then slumped by 176.4% to -$31.7 million in 2023, then jumped by 49.33% to -$16.1 million in 2024, then sank by 183.04% to -$45.5 million in 2025, then slumped by 170.04% to -$122.7 million in 2026.
- The last three Cash from Investing Activities figures came in at -$122.7 million (Q2 2026), -$21.7 million (Q1 2026), and -$45.5 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | -491.00 Mn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | -51.60 Mn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 40.52 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | -122.74 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | -93.00 Mn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | -3.05 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | -44.77 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 44.87 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | - |
| 10 | NutriBand | 94.45 Mn | 91.03 Mn | 181,874.00 | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -122.74 Mn |
| Mar 31, 2026 | -21.71 Mn |
| Dec 31, 2025 | -45.45 Mn |
| Sep 30, 2025 | -22.46 Mn |
| Jun 30, 2025 | -26.55 Mn |
| Mar 31, 2025 | -17.80 Mn |
| Dec 31, 2024 | -16.06 Mn |
| Sep 30, 2024 | -20.71 Mn |
| Jun 30, 2024 | -6.47 Mn |
| Mar 31, 2024 | -19.76 Mn |
| Dec 31, 2023 | -31.69 Mn |
| Sep 30, 2023 | -13.48 Mn |
| Jun 30, 2023 | -12.28 Mn |
| Mar 31, 2023 | -11.74 Mn |
| Dec 31, 2022 | -11.47 Mn |
| Sep 30, 2022 | -49.33 Mn |
| Jun 30, 2022 | -16.12 Mn |
| Mar 31, 2022 | -97.40 Mn |
| Dec 31, 2021 | -86.97 Mn |
| Sep 30, 2021 | -11.63 Mn |
Amneal Pharmaceuticals Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=AMRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();